University Health Network, Toronto
We will be measuring vitamin D metabolites in blood samples drawn from patients undergoing cardiac surgery to determine the correlation with renal function as assessed by serum creatinine. We will include 20 patients in each of the following 3 groups based on serum creatinine measured within 28-days of surgery: 1) normal kidney function (eGFR \> 60 mL/min, n=20), 2) moderate impaired kidney function, eGFR between 30 and 60 mL/min (n=20) and 3) severe kidney dysfunction eGFR \< 30 mL/min (n=20).
Acute Kidney Injuries
Chronic Renal Diseases
| Study Type : | OBSERVATIONAL |
| Estimated Enrollment : | 60 participants |
| Official Title : | Vitamin D Metabolites as Biomarkers for the Identification of Kidney Injury in Cardiac Surgery |
| Actual Study Start Date : | 2024-11-20 |
| Estimated Primary Completion Date : | 2025-07-31 |
| Estimated Study Completion Date : | 2025-12-31 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 18 Years |
| Sexes Eligible for Study: | ALL |
| Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
University Health Network-Toronto General Hospital
Toronto, Ontario, Canada, M5G 2C4